CRMD Q4 2016 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

Q4 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$121,715+430.4% YoY

Gross Profit

$36,38429.9% margin

Operating Income

-$6M-5282.3% margin

Net Income

-$6M-5257.7% margin

EPS (Diluted)

$-0.79

QoQ Revenue Growth

+173.8%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$414,293

Balance Sheet

Total Assets

$22M

Total Liabilities

$4M

Stockholders' Equity

$18M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$121,715	$22,946	+430.4%
Gross Profit	$36,384	-$141,258	+125.8%
Operating Income	-$6M	-$2M	-178.3%
Net Income	-$6M	-$4M	-65.5%